Further studies are needed to better understand how STAT3-GR interactions may regulate proliferation and whether IL-22 administration can overcome CS suppression by increasing the activity of STAT3 or by activating other signaling pathways. This evidence concerns the gene NR3C1 and Cowden syndrome 1.